United States · FDA National Drug Code directory
Neostigmine Methylsulfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70594-069_74ccc6d9-bde5-4c06-b40f-7980c5d5ca90
- Product NDC
- 70594-069
- Form
- INJECTION
- Composition / generic term
- Neostigmine Methylsulfate
- Labeler
- Xellia Pharmaceuticals USA LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210110
- Source listing expiry
- 20261231
Source-listed ingredients
- NEOSTIGMINE METHYLSULFATE — .5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (70594-069-02) / 10 mL in 1 VIAL (70594-069-01) · 70594-069-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →